MarketPeel
Insider Trading Intelligence
Pricing
…
II

Innoviva, Inc.

ARMP
DIRECTOR · ARMATA PHARMACEUTICALS, INC. · CIK 0001080014
FILING MIX · LIFETIME100%/0%
BUYS
12
SELLS
0
TOTAL VALUE
$142.34M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
2,692,604
AVG SELL PX
—
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Innoviva, Inc., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+83.33%+13.22%-0.98%+14.20%+4.71%—
14d12+83.33%+17.00%+0.47%+16.53%+5.93%—
30d12+50.00%+8.29%+0.67%+7.63%-3.50%—
60d12+66.67%+5.71%+2.64%+3.06%-1.78%—
90d12+41.67%-1.27%+1.67%-2.94%-8.76%—
180d12+25.00%-9.79%+5.29%-15.08%-9.40%—
1y12+41.67%+3.43%+12.21%-8.78%-18.31%—
2y12+25.00%-9.49%+25.34%-34.83%-34.01%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ARMP · 2,692,604 shares · as of Mar 31, 2022
04,091,4928,182,98512,274,47716,365,96920212022SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
FLOW · 12 buys / 0 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
—$30,000,000.00——Jan 10, 2023Jan 12, 2023 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
5,385,208$5.00$26.93M16,365,969Mar 31, 2022Apr 1, 2022 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
0$5.00—2,692,604Mar 31, 2022Apr 1, 2022 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
1,807,396$5.00$9.04M1,807,396Feb 9, 2022Feb 11, 2022 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
3,614,792$5.00$18.07M10,980,761Feb 9, 2022Feb 11, 2022 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
1,212,122$3.30$4.00M7,365,969Oct 29, 2021Nov 1, 2021 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
4,285,935$3.25$13.93M6,153,847Mar 17, 2021Mar 17, 2021 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
4,285,935$3.25$13.93M6,153,847Mar 17, 2021Mar 17, 2021 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
1,867,912$3.25$6.07M1,867,912Jan 26, 2021Jan 28, 2021 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
1,867,912$3.25$6.07M1,867,912Jan 26, 2021Jan 28, 2021 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
7,717,661$2.87$22.15M8,710,800Mar 27, 2020Mar 31, 2020 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
7,717,661$2.87$22.15M8,710,800Mar 27, 2020Mar 31, 2020 ↗View →
Other insiders · ARMP
Loading peer insiders…
About this filer
CIK 0001080014
ROLE
Director
PRIMARY
ARMP
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001080014DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback